Mechanisms of sympathetic over activity in the metabolic syndrome: Effects of reversing insulin resistance by drug treatment
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Pioglitazone (Primary)
- Indications Metabolic syndrome
- Focus Pharmacodynamics
- 16 Jan 2013 Planned end date changed from 1 Dec 2008 to 1 Feb 2013 as reported by ClincialTrials.gov.
- 01 Nov 2008 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 02 Nov 2007 Planned start date changed from 1 Mar 2007 to 1 Jan 2008.